Surrozen, Inc./DE (SRZN) stock
SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.61−0.06 (-0.19%)
Close on Nov 13, 2026Market cap $371.53MP/E –Yield –
Surrozen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Surrozen's enterprise value was $272.68M on Nov 11, 2026, against $60.77M a year earlier. Over the last 5 years it ranged from -$57.96M to $276.20M, with a median of -$4.32M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $272.68M | +142.7% |
| 2025 | Dec 31, 2025 | $112.37M | +619.1% |
| 2024 | Dec 31, 2024 | $15.63M | – |
| 2023 | Dec 29, 2023 | -$24.24M | – |
| 2022 | Dec 30, 2022 | -$57.96M | -150.2% |
| 2021 | Dec 31, 2021 | $115.40M | – |
See a number that looks wrong?